Related Experiment Video
Updated: May 1, 2026

06:47
Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
Published on: September 20, 2011
37.4K
Polymer conjugate-based nanomaterials for drug delivery
Journal of Nanoscience and Nanotechnology
|April 16, 2014
Summary
Polymeric amphiphiles form self-assembled nanoparticles for drug delivery. These carriers offer targeted delivery to tumor cells, minimizing side effects and advancing pharmaceutical applications.
Area of Science:
- Polymer Chemistry
- Nanotechnology
- Biomedical Engineering
Background:
- Polymeric amphiphiles self-assemble into nanoparticles with hydrophobic cores and hydrophilic shells.
- These structures are crucial for developing advanced drug delivery systems.
- Their unique properties are highly sought after in biotechnological and pharmaceutical fields.
Purpose of the Study:
- To review the research on self-assembled nanoparticles/micelles of conjugated polymeric amphiphiles.
- To discuss two primary types of self-assembled systems for drug delivery.
- To highlight the advantages of amphiphilic carriers in targeted therapy.
Main Methods:
- Review of literature on self-assembled polymeric amphiphiles.
- Analysis of two distinct drug delivery strategies: post-conjugate drug loading and polymer-drug conjugate self-assembly.
- Discussion of current research developments and challenges.
Main Results:
- Two main types of self-assembled polymeric amphiphile nanoparticles identified: (1) amphiphilic conjugates with subsequent drug loading, and (2) polymer-drug conjugates.
- Amphiphilic carriers demonstrate potential for selective drug delivery to tumor cells.
- These systems offer reduced side effects compared to conventional methods.
Conclusions:
- Self-assembled polymeric amphiphile nanoparticles are promising for targeted drug delivery.
- Further research is needed to address challenges and optimize future development.
- Continued innovation in this area can significantly impact cancer therapy and other pharmaceutical applications.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Drug Delivery Systems: Different Types
406
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
406

